Pathology detection rate of spectral domain optical coherence tomography devices
What is the evidence for systemic effects of intravitreal anti-VEGF agents, and should we be concerned?
Safety profiles of anti-VEGF drugs
Early initial clinical experience with intravitreal aflibercept for wet age-related macular degeneration
A single-arm, investigator-initiated study of the efficacy, safety and tolerability of intravitreal aflibercept injection in subjects with exudative age-related macular degeneration, previously treated with ranibizumab or bevacizumab